TipRanks
Tonix prices 615,025 shares at $16.26 in registered direct offering
📊
AI Sentiment
Positive
7/10
- Home
- TNXP
as of 01-06-2026 3:50pm EST
$15.36
+$0.13
+0.85%
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | CHATHAM |
| Market Cap: | 194.9M | IPO Year: | N/A |
| Target Price: | $70.00 | AVG Volume (30 days): | 510.7K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -16.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.76 - $69.97 | Next Earning Date: | 11-10-2025 |
| Revenue: | $10,299,000 | Revenue Growth: | -8.79% |
| Revenue Growth (this year): | 2.96% | Revenue Growth (next year): | 750.19% |
AI-Powered TNXP Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 21 hours ago
AI Recommendation
hold
Model Accuracy: 77.48%
77.48%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Tonix Pharmaceuticals Holding Corp. News
TNXP Breaking Stock News: Dive into TNXP Ticker-Specific Updates for Smart Investing
Compare TNXP vs Leading Stocks
See how TNXP stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TNXP Tonix Pharmaceuticals Holding Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.